Apellis Pharmaceuticals (APLS) had the highest return in January 2020 by a mid-cap US stock, returning 32.8%.
Apellis Pharmaceuticals (APLS) had the highest return in January 2020 by a mid-cap US stock, returning 32.8%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.